Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

Table 3 Multivariate logistic regression analysis of factors associated with normalized alanine aminotransferase and sustained remission of ursodeoxycholic acid monotherapy in autoimmune hepatitis patients

Factor	Category	Odds ratio (95%CI)	P
ALT (IU/L)	> 200	1
	≤ 200	10.8 (1.64-71.0)	0.013
Age	> 50	1
	≤ 50	1.16 (0.21-6.38)	0.86
IgG	> 2000	1
	≤ 2000	0.65 (0.10-4.32)	0.66
Acute presentation	No	1
	Yes	4.13 (0.15-110.5)	0.4
Histological Grading	A2 or A3	1
	A1	0.76 (0.10-5.88)	0.8
Histological Staging	F2 or F3 or F4	1
	F1	0.41 (0.04-4.44)	0.46
AIH score	> 15	1
(International diagnostic criteria)	≤ 15	2.66 (0.43-16.48)	0.29
AIH score	> 6	1
(Simplified criteria)	≤ 6	5.46 (0.37-81.3)	0.22

ALT: Alanine aminotransferase; AIH: Autoimmune hepatitis.